Pharmacokinetics, Microbial Response, and Pulmonary Outcomes of Multidose Intravenous Azithromycin in Preterm Infants at Risk for Ureaplasma Respiratory Colonization - Merchan, L. Marcela; Hassan, Hazem E.; Terrin, Michael L.; Waites, Ken B.; Kaufman, David A.; Ambalavanan, Namasivayam; Donohue, Pamela; Dulkerian, Susan J.; Schelonka, Robert; Magder, Laurence S.; Shukla, Sagar; Eddington, Natalie D.; et al. (Antimicrobial agents and chemotherapy, 2015)
Keywords: Administration, Intravenous; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - pharmacokinetics; Anti-Bacterial Agents - therapeutic use; Azithromycin; Azithromycin - administration & dosage; Azithromycin - adverse effects; Azithromycin - pharmacokinetics; Azithromycin - therapeutic use; Bronchopulmonary Dysplasia - drug therapy; Bronchopulmonary Dysplasia - metabolism; Clinical Therapeutics; Cytokines - blood; Humans; Infant; Infant, Newborn; Infant, Premature; Inflammation - drug therapy; Inflammation - metabolism; Microbial Sensitivity Tests; Nonlinear Dynamics; Respiratory Tract Infections; Respiratory Tract Infections - drug therapy; Respiratory Tract Infections - microbiology; Treatment Outcome; Ureaplasma; Ureaplasma - drug effects; Ureaplasma - isolation & purification; Ureaplasma - pathogenicity; Ureaplasma Infections; Ureaplasma Infections - drug therapy